RS3PE syndrome with angioimmunoblastic T-cell lymphoma early after the start of immunosuppressive therapy-Reference-Cited by-同舟云学术

RS3PE syndrome with angioimmunoblastic T-cell lymphoma early after the start of immunosuppressive therapy

Published:2023-01-25 Issue:1 Volume:60 Page:60-66
ISSN:0300-9173
Container-title:Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
language:en
Short-container-title:Jpn. j. geriat

Author:

Ishihara Narumi¹,Aota Yasuo¹,Nagata Daichi¹,Saihara Maki¹,Sutoh Arisa²,Okabe Masahiro¹,Wakabayasi Kuninobu³,Yokoyama Tomohisa¹,Gotoh Akihiko²

Affiliation:

1. Department of Internal Medicine, Kohsei Chuo General Hospital

2. Department of Hematology, Tokyo Medical University

3. Department of Medicine, Division of Rheumatology, Showa University School of Medicine

Publisher

The Japan Geriatrics Society

Subject

Geriatrics and Gerontology

Link

https://www.jstage.jst.go.jp/article/geriatrics/60/1/60_60.60/_pdf

Reference17 articles.

1. 1) McCarty DJ, O'Duffy JD, Pearson L, Hunter JB: Remitting seronegative symmetrical synovitis with pitting edema: RS3PE syndrome. JAMA 1985; 254: 2763-2767.

2. 2) Li H, Altman RD, Yao Q: RS3PE: Clinical and Research Development. Curr Rheumatol Rep 2015; 49: 1-6.

3. 3) Olivé A, del Blanco J, Pons M, Vaquero M, Tena X: The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PE. J Rheumatol 1997; 24: 333-336.

4. 4) Origuchi T, Arima K, Umeda M, Kawashiri SY, Tamai M, Nakamura H, et al.: Clinical outcomes in the first year of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome. Mod Rheumatol 2017; 27: 150-154.

5. 5) Olivieri I, Salvarani C, Cantini F: RS3PE syndrome: an overview. Clin Exp Rheumatol 2000; l8: 53-55.